Use of the DiscoveRx Hithunter cAMPII Assay for Direct Measurement of cAMP in Gs and Gi GPCRs
Authors:
- 14 April 2009
- book chapter
- Published by Springer Nature
- Vol. 552, 171-179
Abstract
G protein-coupled receptors (GPCRs) are druggable targets of great interest to the pharmaceutical industry. Generally, functional cell-based assays can be employed to detect agonists (inverse, partial, and full) in addition to allosteric and classical orthosteric antagonists. Several different homogenous assay systems can be used to monitor the signaling cascades of GPCRs. This chapter details the authors’ collective experience of using the DiscoverX Hit Hunter cAMPII kit from GE Healthcare/DiscoverX Corporation for the direct quantification of cAMP levels in Gs and Gi GPCRs.Keywords
This publication has 6 references indexed in Scilit:
- The A, B, Cs of G-protein-coupled receptor pharmacology in assay development for HTSExpert Opinion on Drug Discovery, 2007
- Evaluating Real-Life High-Throughput Screening DataSLAS Discovery, 2005
- cAMP detection methods in HTS: selecting the best from the restNature Reviews Drug Discovery, 2004
- A Homogeneous Enzyme Fragment Complementation Cyclic AMP Screen for GPCR AgonistsSLAS Discovery, 2002
- Enzyme Fragment Complementation: A Flexible High Throughput Screening Assay TechnologyASSAY and Drug Development Technologies, 2002
- A Simple Statistical Parameter for Use in Evaluation and Validation of High Throughput Screening AssaysSLAS Discovery, 1999